Prodomain of the proprotein convertase subtilisin/kexin Furin (ppfurin) protects from tumor progression and metastasis

Carcinogenesis

Volumn 35, Issue 3, 2014, Pages 528-536

  Scamuffa, Nathalie ^a,b   Sfaxi, Fatma ^a,b   Ma, Jia ^a,b   Lalou, Claude ^a,b   Seidah, Nabil ^c   Calvo, Fabien ^d   Khatib, Abdel Majid ^a,b  

^a UNIVERSITÉ DE BORDEAUX   (France)

^b INSERM UMR 1029 ^*  (France)

^c CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^d INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ENZYME INHIBITOR; FURIN; KEXIN; PLATELET DERIVED GROWTH FACTOR; PLATELET DERIVED GROWTH FACTOR A; PROPROTEIN CONVERTASE FURIN; PROTEIN KINASE B; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR; SUBTILISIN; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL CELL; ARTICLE; BREAST CARCINOMA; CARCINOGENICITY; CARCINOMA CELL; CELL SURVIVAL; CHEMOSENSITIVITY; COLON CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE OVEREXPRESSION; GENE REPRESSION; HUMAN; HUMAN CELL; IN VIVO STUDY; LIVER COLORECTAL METASTASIS; METASTASIS; METASTASIS POTENTIAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN DOMAIN; PROTEIN PHOSPHORYLATION; PROTEIN PROCESSING; REAL TIME POLYMERASE CHAIN REACTION; TUMOR GROWTH; WESTERN BLOTTING;

ANIMALS; CELL LINE, TUMOR; DISEASE PROGRESSION; HUMANS; MICE; MICE, INBRED BALB C; NEOPLASM METASTASIS; NIH 3T3 CELLS; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SUBTILISINS;

EID: 84895786251     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt345     Document Type: Article

References (30)

1. Seidah,N.G. et al. (2012) The biology and therapeutic targeting of the proprotein convertases. Nat. Rev. Drug Discov., 11, 367-383.
2. Couture,F. et al. (2012) Role of proprotein convertases in prostate cancer progression. Neoplasia, 14, 1032-1042.
3. Lalou,C. et al. (2013) Inhibition of tumor cells proliferation and migration by the flavonoid furin inhibitor isolated from Oroxylum indicum. Curr. Med. Chem., 20, 583-591.
4. Bassi,D.E. et al. (2005) Proprotein convertases: "master switches" in the regulation of tumor growth and progression. Mol. Carcinog., 44, 151-161.
5. Khatib,A.M. et al. (2002) Proprotein convertases in tumor progression and malignancy: novel targets in cancer therapy. Am. J. Pathol., 160, 1921-1935.
6. Basak,A. et al. (2010) Blockade of furin activity and furin-induced tumor cells malignant phenotypes by the chemically synthesized human furin prodomain. Curr. Med. Chem., 17, 2214-2221.
7. Khatib,A.M. et al. (2001) Inhibition of proprotein convertases is associated with loss of growth and tumorigenicity of HT-29 human colon carcinoma cells: importance of insulin-like growth factor-1 (IGF-1) receptor processing in IGF-1-mediated functions. J. Biol. Chem., 276, 30686-30693.
8. Scamuffa,N. et al. (2008) Selective inhibition of proprotein convertases represses the metastatic potential of human colorectal tumor cells. J. Clin. Invest., 118, 352-363.
9. Lalou,C. et al. (2010) Inhibition of the proprotein convertases represses the invasiveness of human primary melanoma cells with altered p53, CDKN2A and N-Ras genes. PLoS One, 5, e9992.
10. Bontemps,Y. et al. (2008) Inhibitory feature of the proprotein convertases prosegments. Med. Chem., 4, 116-120.
11. Zhong,M. et al. (1999) The prosegments of furin and PC7 as potent inhibitors of proprotein convertases. In vitro and ex vivo assessment of their efficacy and selectivity. J. Biol. Chem., 274, 33913-33920.
12. Benjannet,S. et al. (2001) Post-translational processing of beta-secretase (beta-amyloid-converting enzyme) and its ectodomain shedding. The proand transmembrane/cytosolic domains affect its cellular activity and amyloid-beta production. J. Biol. Chem., 276, 10879-10887.
13. Basak,A. et al. (2009) A novel enediynyl peptide inhibitor of furin that blocks processing of proPDGF-A, B and proVEGF-C. PLoS One, 4, e7700.
14. Bontemps,Y. et al. (2007) Potential opportunity in the development of new therapeutic agents based on endogenous and exogenous inhibitors of the proprotein convertases. Med. Res. Rev., 27, 631-648.
15. Siegfried,G. et al. (2005) Regulation of the stepwise proteolytic cleavage and secretion of PDGF-B by the proprotein convertases. Oncogene, 24, 6925-6935.
16. Schlessinger,J. (2000) Cell signaling by receptor tyrosine kinases. Cell, 103, 211-225.
17. Cicenas,J. (2008) The potential role of Akt phosphorylation in human cancers. Int. J. Biol. Markers, 23, 1-9.
18. Kim,C.S. et al. (2005) AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. Endocrinology, 146, 4456-4463.
19. Siegfried,G. et al. (2003) The proteolytic processing of pro-platelet-derived growth factor-A at RRKR(86) by members of the proprotein convertase family is functionally correlated to platelet-derived growth factor-Ainduced functions and tumorigenicity. Cancer Res., 63, 1458-1463.
20. Lapierre,M. et al. (2007) Opposing function of the proprotein convertases furin and PACE4 on breast cancer cells' malignant phenotypes: role of tissue inhibitors of metalloproteinase-1. Cancer Res., 67, 9030-9034.
21. Page,R.E. et al. (2007) Increased expression of the pro-protein convertase furin predicts decreased survival in ovarian cancer. Cell. Oncol., 29, 289-299.
22. De Vos,L. et al. (2008) MMTV-cre-mediated fur inactivation concomitant with PLAG1 proto-oncogene activation delays salivary gland tumorigenesis in mice. Int. J. Oncol., 32, 1073-1083.
23. Senzer,N. et al. (2012) Phase I trial of "bi-shRNAi(furin)/GMCSF DNA/ autologous tumor cell" vaccine (FANG) in advanced cancer. Mol. Ther., 20, 679-686.
24. Lokker,N.A. et al. (2002) Platelet-derived growth factor (PDGF) autocrine signaling regulates survival and mitogenic pathways in glioblastoma cells: evidence that the novel PDGF-C and PDGF-D ligands may play a role in the development of brain tumors. Cancer Res., 62, 3729-3735.
25. Nakanishi,K. et al. (2002) Critical involvement of the phosphatidylinositol 3-kinase/Akt pathway in anchorage-independent growth and hematogeneous intrahepatic metastasis of liver cancer. Cancer Res., 62, 2971-2975.
26. Baserga,R. (1999) The IGF-I receptor in cancer research. Exp. Cell Res., 253, 1-6.
27. Heldin,C.H. (2012) Autocrine PDGF stimulation in malignancies. Ups. J. Med. Sci., 117, 83-91.
28. Lopez de Cicco,R. et al. (2005) Human carcinoma cell growth and invasiveness is impaired by the propeptide of the ubiquitous proprotein convertase Furin. Cancer Res., 65, 4162-4171.
29. Nejjari,M. et al. (2004) Inhibition of proprotein convertases enhances cell migration and metastases development of human colon carcinoma cells in a rat model. Am. J. Pathol., 164, 1925-1933.
30. Zimmermann,T.S. et al. (2006) RNAi-mediated gene silencing in nonhuman primates. Nature, 441, 111-114.